United States · FDA National Drug Code directory
POTASSIUM PHOSPHATES
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-786_70c7710c-a354-4941-bd46-e64d6ea6b5dc
- Product NDC
- 68462-786
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- POTASSIUM PHOSPHATES
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260312
- Source listing expiry
- 20271231
Source-listed ingredients
- MONOBASIC POTASSIUM PHOSPHATE — 224 mg/mL
- DIBASIC POTASSIUM PHOSPHATE — 236 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, SINGLE-DOSE in 1 CARTON (68462-786-25) / 5 mL in 1 VIAL, SINGLE-DOSE (68462-786-05) · 68462-786-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →